ArticleJournal of pharmaceutical health care and sciences2017

Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports.

Takefumi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.